Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GTSW Biotech is a Malaysia-based biotechnology company focused on the health and wellness sector, particularly within the ASEAN market. Established as a strategic joint venture involving Taiwan's Great Tree Pharmacy and SunWay Biotech, the company specializes in the manufacturing and distribution of clinically-validated nutraceutical ingredients. Its core product portfolio includes ANKASCIN 568-R, a patented red yeast rice extract targeting metabolic and cognitive health, and Vigiis 101-LAB, a probiotic strain for digestive and immune support. The company emphasizes evidence-based science, with its products backed by numerous SCI-indexed publications and clinical trials demonstrating efficacy in blood glucose management and cardiovascular health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GTSW.